Franklin Resources
ABVX

Franklin Resources’s Abivax ABVX Stock Holding History

Franklin Resources’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.9M Sell
299,754
-83,076
-22% -$9.4M 0.01% 745
2026
Q1 		$42.6M Sell
382,830
-66,291
-15% -$7.85M 0.01% 701
2025
Q4 		$60.6M Sell
449,121
-66,969
-13% -$7.31M 0.01% 582
2025
Q3 		$43.8M Sell
516,090
-854,960
-62% -$52.4M 0.01% 688
2025
Q2 		$10.5M Hold
1,371,050
– – ﹤0.01% 1114
2025
Q1 		$8.57M Sell
1,371,050
-95,012
-6% -$643K ﹤0.01% 1152
2024
Q4 		$10.7M Buy
1,466,062
+141,710
+11% +$1.3M ﹤0.01% 1096
2024
Q3 		$12.6M Sell
1,324,352
-70,700
-5% -$847K ﹤0.01% 1043
2024
Q2 		$18.4M Hold
1,395,052
– – 0.01% 884
2024
Q1 		$19.9M Buy
1,395,052
+145,757
+12% +$1.88M 0.01% 868
2023
Q4 		$13.6M Buy
+1,249,295
New +$12.7M 0.01% 859

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources's ABVX Position: Q2 2026 in Review

Franklin Resources reduced its Abivax (ABVX) stake by 22% in Q2 2026, selling an estimated $9.4M and leaving 299,754 shares worth $39.9M. The position accounts for 0.01% of the portfolio, ranked #745.

Franklin Resources first reported a position in ABVX in Q4 2023 and has held it in 11 quarters since. The position peaked at $60.6M in Q4 2025. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Franklin Resources held 299,754 shares of Abivax worth $39.9M as of Q2 2026.
  • Franklin Resources sold 83,076 Abivax shares in Q2 2026, an estimated $9.4M.
  • Abivax made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #745 holding.
  • Franklin Resources first reported a position in Abivax in Q4 2023 and has held it in 11 quarters since.
  • Franklin Resources's Abivax position peaked at $60.6M in Q4 2025.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.